Oric Pharmaceuticals annual depreciation and amortization
2018
2019
2020
2021
2022
2023
2024
2025
Oric Pharmaceuticals Depreciation & Amortization Growth & History (ORIC)
Oric Pharmaceuticals's depreciation and amortization was $1.2M for fiscal 2025.
View full Oric Pharmaceuticals company overviewOric Pharmaceuticals annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.2M | $113,000 | +10.21% |
| 2024 | 2024-12-31 | $1.1M | $75,000 | +7.27% |
| 2023 | 2023-12-31 | $1.0M | $66,000 | +6.83% |
| 2022 | 2022-12-31 | $966,000 | $69,000 | +7.69% |
| 2021 | 2021-12-31 | $897,000 | −$73,000 | −7.53% |
| 2020 | 2020-12-31 | $970,000 | −$58,000 | −5.64% |
| 2019 | 2019-12-31 | $1.0M | $125,000 | +13.84% |
| 2018 | 2018-12-31 | $903,000 | — | — |
Oric Pharmaceuticals quarterly depreciation and amortization
Q1.19
Q2.19
Q3.19
Q1.20
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $264,000 | −$46,000 | −14.84% |
| Q1 2026 | 2026-03-31 | $270,000 | −$32,000 | −10.60% |
| Q4 2025 | 2025-12-31 | $320,000 | — | — |
| Q3 2025 | 2025-09-30 | $288,000 | $18,000 | +6.67% |
| Q2 2025 | 2025-06-30 | $310,000 | $38,000 | +13.97% |
| Q1 2025 | 2025-03-31 | $302,000 | $41,000 | +15.71% |
| Q3 2024 | 2024-09-30 | $270,000 | $13,000 | +5.06% |
| Q2 2024 | 2024-06-30 | $272,000 | $13,000 | +5.02% |
| Q1 2024 | 2024-03-31 | $261,000 | $8,000 | +3.16% |
| Q3 2023 | 2023-09-30 | $257,000 | $36,000 | +16.29% |
| Q2 2023 | 2023-06-30 | $259,000 | $12,000 | +4.86% |
| Q1 2023 | 2023-03-31 | $253,000 | $2,000 | +0.80% |
| Q3 2022 | 2022-09-30 | $221,000 | $4,000 | +1.84% |
| Q2 2022 | 2022-06-30 | $247,000 | $25,000 | +11.26% |
| Q1 2022 | 2022-03-31 | $251,000 | $22,000 | +9.61% |
| Q3 2021 | 2021-09-30 | $217,000 | −$23,000 | −9.58% |
| Q2 2021 | 2021-06-30 | $222,000 | −$24,000 | −9.76% |
| Q1 2021 | 2021-03-31 | $229,000 | −$21,000 | −8.40% |
| Q3 2020 | 2020-09-30 | $240,000 | −$30,000 | −11.11% |
| Q2 2020 | 2020-06-30 | $246,000 | $0 | 0.00% |
| Q1 2020 | 2020-03-31 | $250,000 | $8,000 | +3.31% |
| Q3 2019 | 2019-09-30 | $270,000 | — | — |
| Q2 2019 | 2019-06-30 | $246,000 | — | — |
| Q1 2019 | 2019-03-31 | $242,000 | — | — |
Oric Pharmaceuticals depreciation and amortization trends
Over the last five fiscal years, Oric Pharmaceuticals's depreciation and amortization increased from $970,000 to $1.2M, a change of $250,000. The latest reported quarter, Q2 2026, shows $264,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Oric Pharmaceuticals source filings ↗